With a broad, strategic suite of programs, Goldman Sachs views BioNTech as “being at the nexus of significant developments ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...

We recently published 10 Stocks Jim Cramer Talked About . Moderna Inc. (NASDAQ:MRNA) is one of the stocks on Jim Cramer ...

Moderna will release its fourth-quarter earnings soon, and analysts anticipate a low double-digit loss decline.

Elon Musk says retirement savings 'won't matter' in 20 years. We asked 7 personal finance and AI gurus what they think.

Researchers at Ludwig Maximilian University of Munich developed hybrid PLGA-PBAE nanoparticles that delivered mRNA vaccines ...

The study analysed more than 3,300 clinical notes produced during regular healthcare visits, from 200 anonymised patients, ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...